We are live on
!
Find out more
ACM
Ardent Capital Management Portfolio holdings
AUM
$241M
1-Year Est. Return
23.63%
This Fund
S&P 500
This Quarter
Est. Return
+9.1%
1 Year Est. Return
+23.63%
3 Year Est. Return
+77.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$139M
AUM Growth
+$10.3M
(+8%)
Cap. Flow
+$2.49M
Cap. Flow
% of AUM
1.79%
Top 10 Holdings %
Top 10 Hldgs %
90.59%
Holding
30
New
3
Increased
9
Reduced
10
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
|
+$1.14M |
| 2 |
PayPal
PYPL
|
+$919K |
| 3 |
Johnson & Johnson
JNJ
|
+$437K |
| 4 |
Stryker
SYK
|
+$277K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$261K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$529K |
| 2 |
Apple
AAPL
|
+$126K |
| 3 |
iShares Russell 1000 ETF
IWB
|
+$71.3K |
| 4 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$69.9K |
| 5 |
JPMorgan Chase
JPM
|
+$46.3K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 39.95% |
| 2 | Healthcare | 22.79% |
| 3 | Technology | 17.13% |
| 4 | Communication Services | 10.81% |
| 5 | Consumer Staples | 5.27% |
Similar funds
RS
AP
CIA
RTL
HIP
PFWA
GBL
AA
Ardent Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Ardent Capital Management held 30 positions worth $139M, up 8% from $129M the previous quarter. Its ten largest holdings account for 91% of the portfolio.
Ardent Capital Management's Q1 2023 filing shows 3 new, 9 increased, 10 reduced and 1 closed positions. Its largest new stake was Jounce Therapeutics, Inc. Common Stock: 923,463 shares worth $1.71M. The largest sale was Bristol-Myers Squibb, an estimated $529K.
By sector, the portfolio is most concentrated in Financials at 40% of assets, down from 43% a quarter earlier, followed by Healthcare and Technology.
- Ardent Capital Management's largest Q1 2023 buy was Jounce Therapeutics, Inc. Common Stock: 923,463 shares worth $1.71M.
- Ardent Capital Management added most to Johnson & Johnson in Q1 2023, an estimated $437K increase.
- Ardent Capital Management's biggest Q1 2023 reduction was Apple, cutting an estimated $126K.
- Ardent Capital Management fully exited Bristol-Myers Squibb in Q1 2023, selling an estimated $529K.
- Ardent Capital Management's ten largest holdings make up 91% of its $139M portfolio in Q1 2023.
- Ardent Capital Management opened 3 new positions and closed 1 in Q1 2023.
- Ardent Capital Management's portfolio value rose 8% quarter-over-quarter to $139M.
Based on Ardent Capital Management's 13F filing for Q1 2023, filed 12 May 2023.